SKC podcast

Dr. Lydia Frick, market access manager of SKC, and Prof. Matthias P. Schönermark M.D., Ph.D. present the top topics of these congresses, such as cost-effectiveness analyses, innovative contract models and affordability. They highlight the observed uncertainty in the industry caused by political processes, such as the harmonization of benefit assessment through EU-HTA, and the demand for a change of mentality in the HTA process.

You can find Profcast #11 Advanced Therapies and World EPA Congress 2023 - a retrospective in German language on Spotify und Apple Podcast. Listen now!

About the Profcast

Our SKC podcast series "The Profcast - rare diseases and their therapies" aims to address the special circumstances of patients with rare diseases, the associated medicine and the challenges for research, development, economics and reimbursement. For this purpose, Prof. Matthias P. Schönermark, M.D., Ph.D., managing director of SKC, speaks with patient representatives, payers, clinicians and scientists as well as industry representatives and also focuses on specific diseases. The word Profcast is a reference to professionals or professors, whom he welcomes as his guests.

The ambition behind this is to give an appropriate space to rare diseases and their treatment sine ira et studio. After all, the motto of the Rare Disease Day states it so aptly: "Rare is many". It is estimated that 4 million people in Germany and 300 million people worldwide are affected by a rare disease. In keeping with the Rare Disease Day, which traditionally takes place on the last day of February, the Profcast is published on the last day of a month.